A retrospective study assessing the predictors of the response, in addition to its efficacy and safety
Latest Information Update: 31 Jan 2023
At a glance
- Drugs Anamorelin (Primary)
- Indications Cachexia
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 31 Jan 2023 New trial record
- 14 Jan 2023 Results published in the Supportive Care in Cancer